SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-076926
Filing Date
2013-02-26
Accepted
2013-02-26 16:20:40
Documents
1
Group Members
AGTC ADVISORS FUND, L.P.AGTC PARTNERS, L.P.APPLIED GENOMIC TECHNOLOGY CAPITAL FUND, L.P.EDWIN M. KANIA, JR.FLAGSHIP VENTURES 2007 GENERAL PARTNER, LLCFLAGSHIP VENTURES FUND 2007, L.P.FLAGSHIP VENTURES MANAGEMENT, INC.NEWCOGEN EQUITY INVESTORS LLCNEWCOGEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 d491319dsc13da.htm SC 13D/A 342690
  Complete submission text file 0001193125-13-076926.txt   344536
Mailing Address
Business Address 150 CAMBRIDGEPARK DR CAMBRIDGE MA 02140
NEWCOGEN GROUP LLC (Filed by) CIK: 0001097548 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 610N LINCOLN STREET WALTHAM MA 02451
Business Address 610N LINCOLN STREET WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Subject) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86104 | Film No.: 13642965
SIC: 2835 In Vitro & In Vivo Diagnostic Substances